Targeting melanoma growth and viability reveals dualistic functionality of the phosphonothionate analogue of carba cyclic phosphatidic acid

BACKGROUND: Although the incidence of melanoma in the U.S. is rising faster than any other cancer, the FDA-approved chemotherapies lack efficacy for advanced disease, which results in poor overall survival. Lysophosphatidic acid (LPA), autotaxin (ATX), the enzyme that produces LPA, and the LPA recep...

Descripción completa

Detalles Bibliográficos
Autores principales: Altman, Molly K, Gopal, Vashisht, Jia, Wei, Yu, Shuangxing, Hall, Hassan, Mills, Gordon B, McGinnis, A Cary, Bartlett, Michael G, Jiang, Guowei, Madan, Damian, Prestwich, Glenn D, Xu, Yong, Davies, Michael A, Murph, Mandi M
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895597/
https://www.ncbi.nlm.nih.gov/pubmed/20529378
http://dx.doi.org/10.1186/1476-4598-9-140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2895597/
https://www.ncbi.nlm.nih.gov/pubmed/20529378
http://dx.doi.org/10.1186/1476-4598-9-140

Ejemplares similares